Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome;Significato clinico degli anticorpi anti acido lisobisfosfatidico nei pazienti con sindrome da antifosfolipidi primaria

Reumatismo

Volumn 62, Issue 2, 2010, Pages 107-112

  Olivieri, S ^a   Ruffatti, A ^a   Bontadi, A ^a   Cavazzana, A ^a   Salvan, E ^a   Cuffaro, S ^a   Giunco, S ^a   Punzi, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiphospholipid antibodies; Antiphospholipid antibody syndrome; Lysobisphosphatidic acid

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPID ANTIBODY; BIOLOGICAL MARKER; BIS(MONOACYLGLYCERYL)PHOSPHATE; IMMUNOLOGIC FACTOR; LYSOPHOSPHOLIPID; MONOACYLGLYCEROL;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING TEST; CLINICAL EXAMINATION; CLINICAL LABORATORY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; BLOOD; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREDICTIVE VALUE;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYSOPHOSPHOLIPIDS; MALE; MIDDLE AGED; MONOGLYCERIDES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 77954894936     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kandiah DA, Sali A, et al. Current insighits into the "antiphospholipid" sindrome: clinical, immunological and molecular aspects. Adv Immunol 1998; 70: 507-63.
2. Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, et al. Anti-lysobispho sphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol 2005; 140: 173-80.
3. Sorice M, Ferro D, Misasi R, Pittoni V, Longo A, Circella A, et al. Evidence for anticoagulant activity and β 2 -GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies. Thromb Haemost 2002; 87:735-41.
4. Galve-de-Rochemonteix B, Lobayashi T, Rosnoblet C, Lindsay M, Parton RG, Reber G, et al. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20: 563-74.
5. Miyakis S, Lockshin MD, Atsumi M, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
6. Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni PL, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-8.
7. Pierangeli SS, Harris EN. Clinical laboratory testing for the antiphospholipid syndrome. Clin Chim Acta 2005; 357: 17-33.
8. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC. Proposal for the measurement of anti-b2 Glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-2.
9. Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GR. Beta 2-Glycoprotein I reactivity of mon oclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 1994; 37: 1453-61.
10. Finazzi G, Brancaccio V, Moia M, Ciavarella N, Mazzucconi G, Schinco PC, et al. Natural history and risk factors for thrombosis in 360 patients with antiphos pholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 1996; 100: 530-6.
11. Ruffatti A, Olivieri S, Tonello M, Bortolati M, Bison E, Salvan E, et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost. 2008; 6: 1693-6.